Related references
Note: Only part of the references are listed.MANAGEMENT OF ENDOCRINE DISEASE GH excess: diagnosis and medical therapy
Marianne Andersen
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2014)
Acromegaly with negative pituitary MRI and no evidence of ectopic source: the role of transphenoidal pituitary exploration?
Sameera Daud et al.
PITUITARY (2011)
Efficacy and complications of neurosurgical treatment of acromegaly
Anna Krzentowska-Korek et al.
PITUITARY (2011)
A Consensus on Criteria for Cure of Acromegaly
A. Giustina et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Effects of Initial Therapy for Five Years with Somatostatin Analogs for Acromegaly on Growth Hormone and Insulin-Like Growth Factor-I Levels, Tumor Shrinkage, and Cardiovascular Disease: A Prospective Study
Annamaria Colao et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Guidelines for Acromegaly Management: An Update
S. Melmed et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Wide variation in surgical outcomes for acromegaly in the UK
P. R. Bates et al.
CLINICAL ENDOCRINOLOGY (2008)
Clinical use of cabergoline as primary and adjunctive treatment for acromegaly
V. J. Moyes et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2008)
Extensive clinical experience: Changing patterns in diagnosis and therapy of acromegaly over two decades
Lisa Nachtigall et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Preoperative octreotide treatment in newly diagnosed acromegalic patients with macroadenomas increases cure short-term postoperative rates: A prospective, randomized trial
Sven M. Carlsen et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Acromegaly
Philippe Chanson et al.
ORPHANET JOURNAL OF RARE DISEASES (2008)
Current diagnosis of acromegaly
Rocio A. Cordero et al.
REVIEWS IN ENDOCRINE & METABOLIC DISORDERS (2008)
Risk of colorectal neoplasm in patients with acromegaly: A meta-analysis
Theodoros Rokkas et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2008)
Radiosurgery of growth hormone-producing pituitary adenomas: factors associated with biochemical remission
Bruce E. Pollock et al.
JOURNAL OF NEUROSURGERY (2007)
Primary treatment of acromegaly with octreotide LAR: a long-term (up to nine years) prospective study of its efficacy in the control of disease activity and tumor shrinkage
R Cozzi et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
The implication of somatotroph adenoma phenotype to somatostatin analog responsiveness in acromegaly
S Bhayana et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
The outcome of surgery in 668 patients with acromegaly using current criteria of biochemical 'cure'
P Nomikos et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2005)
The long-term efficacy of conventional radiotherapy in patients with GH-secreting pituitary adenomas
G Minniti et al.
CLINICAL ENDOCRINOLOGY (2005)
Systemic complications of acromegaly: Epidemiology, pathogenesis, and management
A Colao et al.
ENDOCRINE REVIEWS (2004)
Four-year treatment with octreotide-long-acting repeatable in 110 acromegalic patients: Predictive value of short-term results?
R Cozzi et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
Guidelines for acromegaly management
S Melmed et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2002)
Long-term safety and efficacy of depot long-acting somatostatin analogs for the treatment of acromegaly
J Ayuk et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2002)
Risk factors for glucose intolerance in active acromegaly
A Kreze et al.
BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH (2001)
Prevalence of diabetes in acromegaly and Cushing's disease
H Biering et al.
ACTA MEDICA AUSTRIACA (2000)
Share Paper
